ELMD vs. BFLY, ESTA, EYE, BBNX, EMBC, BVS, AXGN, CBLL, AVNS, and IRMD
Should you be buying Electromed stock or one of its competitors? The main competitors of Electromed include Butterfly Network (BFLY), Establishment Labs (ESTA), National Vision (EYE), Beta Bionics (BBNX), Embecta (EMBC), Bioventus (BVS), AxoGen (AXGN), CeriBell (CBLL), Avanos Medical (AVNS), and Iradimed (IRMD). These companies are all part of the "medical equipment" industry.
Electromed vs.
Butterfly Network (NYSE:BFLY) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability, community ranking, valuation and media sentiment.
In the previous week, Electromed had 11 more articles in the media than Butterfly Network. MarketBeat recorded 16 mentions for Electromed and 5 mentions for Butterfly Network. Butterfly Network's average media sentiment score of 0.54 beat Electromed's score of 0.44 indicating that Butterfly Network is being referred to more favorably in the media.
Butterfly Network has a beta of 2.47, indicating that its share price is 147% more volatile than the S&P 500. Comparatively, Electromed has a beta of 0.33, indicating that its share price is 67% less volatile than the S&P 500.
37.9% of Butterfly Network shares are owned by institutional investors. Comparatively, 40.8% of Electromed shares are owned by institutional investors. 27.3% of Butterfly Network shares are owned by insiders. Comparatively, 14.0% of Electromed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Electromed has a net margin of 11.34% compared to Butterfly Network's net margin of -129.25%. Electromed's return on equity of 15.71% beat Butterfly Network's return on equity.
Electromed has lower revenue, but higher earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.
Butterfly Network presently has a consensus target price of $3.00, indicating a potential downside of 29.82%. Electromed has a consensus target price of $38.00, indicating a potential upside of 35.86%. Given Electromed's stronger consensus rating and higher possible upside, analysts plainly believe Electromed is more favorable than Butterfly Network.
Electromed received 12 more outperform votes than Butterfly Network when rated by MarketBeat users. Likewise, 90.00% of users gave Electromed an outperform vote while only 66.67% of users gave Butterfly Network an outperform vote.
Summary
Electromed beats Butterfly Network on 13 of the 19 factors compared between the two stocks.
Get Electromed News Delivered to You Automatically
Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Electromed Competitors List
Related Companies and Tools
This page (NYSE:ELMD) was last updated on 2/23/2025 by MarketBeat.com Staff
